Cargando…
The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
Multiple myeloma (MM) is typically featured by the increased levels of inflammatory cytokines in the neoplastic plasma cells (PCs) producing monoclonal immunoglobulin. PCs proliferate in the bone marrow, which will lead to extensive skeletal destruction with osteolytic lesions, osteopenia, or pathol...
Autores principales: | Liu, Cheng-Der, Chang, Chun-Chun, Huang, Wei-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323651/ https://www.ncbi.nlm.nih.gov/pubmed/34386363 http://dx.doi.org/10.4103/tcmj.tcmj_141_20 |
Ejemplares similares
-
Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation
por: Chang, Chun-Chun, et al.
Publicado: (2020) -
The molecular pathogenesis of multiple myeloma
por: Bolli, Niccolò, et al.
Publicado: (2020) -
Pathogenesis and treatment of multiple myeloma
por: Yang, Peipei, et al.
Publicado: (2022) -
Recent Progress of Exosomes in Multiple Myeloma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Strategies
por: Wang, Xi, et al.
Publicado: (2021) -
Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
por: Biernacki, Tamás, et al.
Publicado: (2020)